Trial in Periodontal Tissue Regeneration Using Fibroblast Growth Factor-2

NCT00514657 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

91

Enrollment

INDUSTRY

Sponsor class

Conditions

Periodontitis

Interventions

DRUG: Trafermin (genetical recombinant of human basic Fibroblast Growth Factor)

Sponsor

Kaken Pharmaceutical